Medartis Holding AG Share Price
Equities
MED
CH0386200239
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 88.70 CHF | -1.44% |
|
-1.33% | +0.57% |
| 11-24 | Medartis Names New Finance Chief | MT |
| 11-24 | Medartis appoints Peter Hackel as new chief financial officer | RE |
| Capitalization | 1.1B 1.42B 1.2B 1.04B 1.94B 129B 2.03B 12.82B 5.07B 61.99B 5.33B 5.22B 223B | P/E ratio 2025 * |
156x | P/E ratio 2026 * | 57.1x |
|---|---|---|---|---|---|
| Enterprise value | 1.18B 1.52B 1.29B 1.12B 2.08B 138B 2.17B 13.74B 5.44B 66.48B 5.72B 5.6B 239B | EV / Sales 2025 * |
4.39x | EV / Sales 2026 * | 3.71x |
| Free-Float |
34.62% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Medartis Holding AG
| 1 day | -1.44% | ||
| 1 week | -1.33% | ||
| Current month | -1.33% | ||
| 1 month | -0.34% | ||
| 3 months | +18.42% | ||
| 6 months | +10.32% | ||
| Current year | +0.57% |
| 1 week | 87.7 |  | 91.3 |
| 1 month | 85 | | 97.5 |
| Current year | 83.6 | | 97.5 |
| 1 year | 61 | | 97.5 |
| 3 years | 44.15 | | 99.4 |
| 5 years | 44.15 | | 148.4 |
| 10 years | 31.6 | | 148.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthias Schupp
CEO | Chief Executive Officer | 62 | 31/10/2024 |
Peter Hackel
DFI | Director of Finance/CFO | 57 | 31/12/2025 |
Mario Della Casa
COO | Chief Operating Officer | 51 | 30/09/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
H. C. Straumann
CHM | Chairman | 63 | 02/11/1997 |
Willi Miesch
BRD | Director/Board Member | 62 | 31/12/2009 |
Damien Tappy
BRD | Director/Board Member | 57 | 31/12/2017 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.44% | -1.33% | +27.63% | +19.06% | 1.42B | |
| -1.14% | -3.05% | -8.46% | +31.51% | 137B | |
| -2.05% | +2.01% | +26.51% | +7.97% | 14.65B | |
| -2.30% | +7.65% | -14.66% | -63.78% | 6.53B | |
| -0.88% | -5.75% | -26.50% | +127.22% | 6.46B | |
| +0.75% | -.--% | -.--% | +20.65% | 3.63B | |
| -1.06% | -2.97% | +40.86% | +33.36% | 2.91B | |
| -1.18% | -1.64% | -1.65% | -18.99% | 2.09B | |
| Average | -1.16% | -0.12% | +5.47% | +19.63% | 21.84B | |
| Weighted average by Cap. | -1.21% | -2.19% | -5.05% | +28.61% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 269M 347M 294M 255M 473M 31.42B 495M 3.13B 1.24B 15.13B 1.3B 1.27B 54.46B | 326M 420M 356M 309M 573M 38.07B 599M 3.79B 1.5B 18.33B 1.58B 1.54B 65.97B |
| Net income | 7.36M 9.49M 8.03M 6.97M 12.94M 859M 13.53M 85.53M 33.86M 414M 35.58M 34.84M 1.49B | 19.94M 25.7M 21.75M 18.88M 35.06M 2.33B 36.65M 232M 91.71M 1.12B 96.36M 94.38M 4.03B |
| Net Debt | 79.83M 103M 87.11M 75.61M 140M 9.32B 147M 928M 367M 4.49B 386M 378M 16.16B | 107M 138M 117M 102M 189M 12.52B 197M 1.25B 493M 6.03B 518M 508M 21.7B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/02/26 | 88.70 CHF | -1.44% | 2,212 |
| 05/02/26 | 90.00 CHF | -0.11% | 4,735 |
| 04/02/26 | 90.10 CHF | +1.12% | 3,365 |
| 03/02/26 | 89.10 CHF | -0.45% | 2,558 |
| 02/02/26 | 89.50 CHF | -0.44% | 2,953 |
Delayed Quote Swiss Exchange, February 06, 2026 at 04:31 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MED Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition